Heart Rate News and Research

RSS

Heart rate is determined by the number of heartbeats per unit of time, typically expressed as beats per minute (BPM), it can vary with as the body's need for oxygen changes, such as during exercise or sleep.

Higher heart rate linked to shorter life expectancy

If you are a person who already has stable heart disease, how fast your heart beats at rest can predict your risk of dying, not only from heart disease but all other causes, Dr. Eva Lonn told the Canadian Cardiovascular Congress 2010, co-hosted by the Heart and Stroke Foundation and the Canadian Cardiovascular Society.

27 Oct 2010

Stress can literally show up on the face

According to an Australian stylist stress affects the health as well as appearance. Gregory Landsman, the author of Face and Fitness said that high stress level is immediately visible on a person’s face.

26 Oct 2010

Marathon running without proper training can damage the heart

Is running a marathon good for you or can it damage the heart?

25 Oct 2010

New Canadian Cardiovascular Society guidelines support clinicians in practicing evidence-based medicine

Summaries of a number of new Canadian Cardiovascular Society guidelines and position statements offering the most up to date information to support clinicians in practicing evidence-based medicine were released at the Canadian Cardiovascular Congress 2010 this week.

25 Oct 2010

Anxiety sensitivity levels may help in choosing medical treatment for AF patients

Levels of anxiety sensitivity may be important in choosing medical treatment for patients with heart failure and atrial fibrillation (AF), Montreal Heart Institute researchers today told the Canadian Cardiovascular Congress 2010, co-hosted by the Heart and Stroke Foundation and the Canadian Cardiovascular Society.

25 Oct 2010

FDA announces new label for HIV antiviral drug Invirase

The U.S. Food and Drug Administration today announced that new safety information has been added to the label for the HIV antiviral drug Invirase (saquinavir), describing potentially life-threatening side effects on the heart when used with Norvir (ritonavir), another HIV antiviral medication.

22 Oct 2010

Potential SIDS cause found

A baffling condition Sudden Infant Death Syndrome (SIDS) that leads to the unexplained deaths of many infants worldwide may have been explained in new Australian research. The researchers monitored babies as they slept on their bellies and found that they have reduced blood pressure and an increased heart rates, compared with when they slept on their backs as recommended. This effect is seen more in babies aged two to three months, the age when babies are most at risk of SIDS.

21 Oct 2010

U-M hopes to make concept of recycling pacemakers a life-saving reality

Millions worldwide die each year because they can't afford a pacemaker. Meanwhile heart patients in the United States say they'd be willing to donate theirs after death to someone in need.

20 Oct 2010

Study: Gastric function and autonomic nervous system are impaired in obese individuals

Research on obesity examining the role of hormones and the autonomic functions of the digestive system was presented at the 75th Annual Scientific Meeting of the American CoIlege of Gastroenterology.

19 Oct 2010

Obese have impaired autonomic function which may lead to overeating

Research on obesity examining the role of hormones and the autonomic functions of the digestive system was presented at the 75th Annual Scientific Meeting of the American CoIlege of Gastroenterology.

18 Oct 2010

Abreu btt 700 System for continuous temperature monitoring launched at ASA Annual Meeting

Conquering the last frontier for monitoring vital signs, Brain Tunnelgenix Technologies Corp. is introducing the Abreu btt™ 700 System for continuous temperature monitoring at the Annual Meeting of the American Society of Anesthesiologists (ASA) today. The Abreu btt 700 System sensor is approved by the U.S. Food and Drug Administration for placement on the skin and to be used during surgical procedures, recovery room, intensive care and general patient monitoring.

18 Oct 2010

BIOTRONIK announces European release of TI Trend Chart

BIOTRONIK SE Co. & KG, leading manufacturer of cardiovascular devices, has announced the European release of its Thoracic Impedance (TI) Trend Chart via its pioneering BIOTRONIK Home Monitoring technology and Lumax 540 implantable cardiac defibrillator (ICD) series.

15 Oct 2010

Onyx II 9560 wireless fingertip pulse oximeter helps rescue Chilean miners

Nonin Medical, Inc., the inventor of the world's first fingertip and wireless-fingertip pulse oximeter, announced today that its Onyx II 9560 wireless fingertip pulse oximeter was used in the effort to rescue 33 Chilean miners who were trapped in a Copiapo, Chile mine since August 5.

14 Oct 2010

Yoga decreases anxiety in childhood cancer patients and their parents

A new study reports that yoga can reduce the stress of cancer diagnosis and treatment experienced by childhood cancer patients and their parents. The findings were published in the September/October 2010 edition of Journal of Pediatric Oncology Nursing, published by the Association of Pediatric Hematology/Oncology Nurses (APHON).

11 Oct 2010

UH researchers receive grant to develop Blue Scale device to track heart failure

As more and more medical care is provided in the home, health specialists say it is critical for people to be able to monitor themselves and make informed judgments about their health. A group of researchers in the Abramson Center for the Future of Health at the University of Houston (UH) received a $250,000 pre-seed grant from the Texas Emerging Technology Fund (ETF) for a system that assesses cardiac function in the home and alerts the user to the need for intervention.

11 Oct 2010

Abbott to withdraw Meridia medicine from the U.S. market

Abbott will voluntarily withdraw Meridia (sibutramine) from the U.S. market at the request of the U.S. Food and Drug Administration (FDA).

11 Oct 2010

Researchers to conduct trial to improve drug abstinence, relapse rates

A $15.7 million award from the National Institute on Drug Abuse (NIDA) is allowing researchers to see whether consistent exercise will help people abstain from stimulant abuse.

6 Oct 2010

FDA grants marketing clearance for EarlySense's EverOn Central Display Station

EarlySense announced today that its EverOn Central Display Station (CDS) has been cleared for marketing by the U.S. Food and Drug Administration (FDA). The FDA clearance covers the ability of the system to collect real time vital sign information from up to 36 EverOn bedside monitors and display the information on a computer screen at the nurse's station.

5 Oct 2010

Merck's boceprevir Phase III studies for HCV to be presented at 61st AASLD

Merck today announced that final results from two pivotal Phase III studies of boceprevir, its investigational oral hepatitis C protease inhibitor, will be presented in oral plenary sessions at the 61st Annual Meeting of the American Association for the Study of Liver Diseases (AASLD), which is taking place from Oct. 29 through Nov. 2 in Boston. Results for boceprevir in response-guided therapy strategies, which evaluated treatment durations shorter than current standard therapy, will be presented during the meeting.

4 Oct 2010

Neupro improves quality of life in Parkinson's disease patients

People with Parkinson's disease who used once-daily Neupro® (rotigotine) in the RECOVER trial achieved improvements in quality of life, in addition to previously reported beneficial effects on motor and non-motor symptoms.

4 Oct 2010